Global Precision Medicine IT Solutions for Oncology—Companies to Action, 2017

Early Movers Expect to Facilitate Evidence-Based Cancer Care

USD 3,000.00

* Required Fields

USD 3,000.00

PAY BY INVOICE

Be the first to review this product

Author: Koustav Chatterjee, Natasha Gulati, and Daniel RupparDefinitionPrecision medicine for oncology is defined as patient-specific cancer care that is aided by a targeted software suite. The realm of precision medicine is determined by providers' willingness and ability to capture and normalize disparate patient data - including clinical, socioeconomic, behavioral, and genomic - to identify evidence-based treatments that are ideal for each patient.Report OutlookThis report profiles vendors that are offering promising, disruptive, and pioneering solutions across diverse domains in precision medicine for oncology. It brings the most recent and successful and/or high-potential companies to light. The focus has

Table of Contents

Methodology
Scope and Segmentation
1. Executive Summary
Global Precision Medicine IT Market Snapshot
Global Precision Medicine IT Solutions for Oncology—Analysis of Companies to Action
Strategic Imperatives for Industry Stakeholders to Explore Precision Medicine
Precision Medicine—Regional Market Overview
Precision Medicine—Future Impact on Healthcare
Precision Medicine—Strategic Imperatives for Success and Growth
2. Companies to Action Overview
Industry Convergence Driving Disruption and Innovation
Convergence in Healthcare Creates Both Opportunities and Threats
Frost & Sullivan Companies to Action Have the Potential to Disrupt Current Healthcare Industry Paradigms
3. Digital Health Industry Snapshot
Digital Health Benefits from Broader Industry Convergence
Digital Health Priorities
Digital Health Market Segmentation and Convergence
4. Precision Medicine for Oncology Market Overview
What is Precision Medicine?
Market Challenges, Opportunities, and Concerns
Current State of Precision Medicine Adoption
Key Data Sources for Precision Medicine
Impact of Precision Medicine on Oncology
Impact of Key Market Influencers
Operational Architecture of Precision Medicine for Oncology
Stakeholders’ Digital Health Solutions
Digital Health Solutions Applicable Across the Care Continuum
Digital Health Companies Supporting Precision Medicine for Oncology—Vendor Landscape
Top Industry Needs and Vendor Strategies
Precision Medicine IT Solutions for Oncology—C2A Key Findings
5. C2A Profiles
2bPrecise (Allscripts)
Cerner
GenomOncology
IBM Watson Health
N-of-One
NantHealth
Navican (an Intermountain Healthcare Company)
Quest Diagnostics
Royal Philips
Via Oncology
6. The Last Word
Precision Medicine—Future Impact on Healthcare
Precision Medicine—Strategic Imperatives for Success and Growth
Legal Disclaimer
7. Appendix
List of Vendors Assessed
Abbreviation List
8. The Frost & Sullivan Story

Infographic



List of Figures & Charts

1. Digital Health C2A: Digital Health Solutions for Diagnosis—Precision Medicine IT Solutions for Oncology, Global, 2017
2. Digital Health C2A: Digital Health Solutions for Treatment—Precision Medicine IT Solutions for Oncology, Global, 2017
3. Digital Health C2A: Digital Health Solutions for Prevention—Precision Medicine IT Solutions for Oncology, Global, 2017
4. Digital Health C2A: Select List of Vendors Assessed—Precision Medicine IT Solutions for Oncology, Global, 2017


1. Digital Health C2A: Vendors Profiled in this Research—Precision Medicine IT Solutions for Oncology, Global, 2017
2. Digital Health C2A: Vendors’ Best Practices—Precision Medicine IT Solutions for Oncology, Global, 2017
3. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology, Global, 2017
4. Digital Health C2A: Indicative Value of Precision Medicine by Industry Stakeholder—Precision Medicine IT Solutions for Oncology, US, 2017
5. Digital Health C2A: Precision Medicine Percent Revenue Contribution by Region, Global, 2016
6. Digital Health C2A: C2A Value Creators, Global, 2017
7. Digital Health C2A: Digital Health Market Segmentation and Convergence, Global, 2017
8. Digital Health C2A: Challenges, Opportunities, and Concerns—Precision Medicine IT Solutions for Oncology, Global, 2017
9. Digital Health C2A: Precision Medicine Adoption as per HIMSS Analytics Survey, US, 2016 and 2017
10. Adoption of Precision Medicine Approaches by End User, US, 2017
11. Digital Health C2A: Precision Medicine Key Data Sources, Global, 2017
12. Digital Health C2A: Impact of Key Market Influencers—Precision Medicine IT Solutions for Oncology, Global, 2017
13. Digital Health C2A: Stakeholders’ Digital Health Solutions—Precision Medicine IT Solutions for Oncology, Global, 2017
14. Digital Health C2A: Shortlisted Vendors' Ability to Address Industry Needs—Precision Medicine IT Solutions for Oncology Global, 2017



Related Research

Release Date : 06-Dec-17

Region : Asia Pacific

Release Date : 09-Nov-17

Region : Global

Release Date : 11-Oct-17

Region : Asia Pacific

Release Date : 15-Nov-16

Region : North America

Release Date : 30-Sep-16

Region : North America

Release Date : 06-Sep-16

Region : North America

Release Date : 31-Aug-16

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.